Pharming Group N.V. - ADR
PHAR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$865.62M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $865.62 Million |
|---|---|
| Enterprise Value | $820.63 Million |
| Earnings per Share | $0.04 |
| Beta | 0.09 |
| Outstanding Shares | 70,778,120 |
Return
| Return on Equity | 8.49% |
|---|---|
| Return on Assets | 4.91% |
| Return on Invested Capital | 1663.96% |
Valuation & Multiples
| P/E Ratio | 34.69 |
|---|---|
| PEG | 18.05 |
| Price to Sales | 2.55 |
| Price to Book Ratio | 4.25 |
| Enterprise Value to Revenue | 2.22 |
| Enterprise Value to EBIT | 0.13 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 27, 2026
EPS Estimate
$0.21
Consensus analyst estimateRevenue Estimate
$117.60 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$107.55 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 3.20% |
|---|---|
| Total Invested | $130▼ 100.00% |
| Investors Holding | 1▼ 17.00% |
About Pharming Group N.V.
407 employees
CEO: Sijmen de Vries
Based in Leiden, the Netherlands, Pharming Group N.V. operates as a biopharmaceutical firm dedicated to advancing and marketing protein replacement therapies and precise medical solutions. Its global efforts, spanning the United States, ...